Find information on thousands of medical conditions and prescription drugs.

Parkinson's disease

Parkinson's disease (PD; paralysis agitans; also known as Parkinson disease in the U.S.) is a neurodegenerative disease of the substantia nigra, an area in the basal ganglia of the brain. The disease was first recognised and its symptoms documented in 1817 in An Essay on the Shaking Palsy by the British physician Dr James Parkinson; the associated biochemical changes in the brain of patients were identified in the 1960s. Some gene defects associated with the disease were identified only recently; others remain unknown. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The disease involves a progressive disorder of the extrapyramidal system, which controls and adjusts communication between neurons in the brain and muscles in the human body. It also commonly involves depression and disturbances of sensory systems.

Parkinson's disease is widespread, with a prevalence estimated between 100 and 250 cases per 100,000 in North America; globally prevalence estimates range from a low of 15 per 100,000 in China to a high of 657 per 100,000 in Argentina. Because prevalence rates can be effected by socio-ecomically driven differences in survival, incidence is a more sensitive indicator: rates have ranged from 1.5 per 100,000 in China to a high of 14.8 per 100,000 in Finland.

About 2% of the population develops the disease some time during life, though the mean age at onset is 58-60. Symptoms usually begin in the upper extremities, and are usually unilateral (one-sided) or asymmetrical at onset.

Debate over Causes: A Complex Etiology is Probable

The cause of Parkinson's disease is not known (idiopathic). There are, however, many theories.

Genetic

Geneticists have, since 1997, found nine different specific genetic defects, each of which causes the disease in one or a few families with extraordinarily high incidences of the disease, but such families are rare.

While a strong inheritance pattern occurs in only a very small percentage of cases, an affected individual is three to four times more likely than an unaffected individual to have a close relative with Parkinson's. Having a parent with Parkinson's raises one's lifetime risk of developing the disorder threefold, from the general population's figure of 2% to about 6%. Genes that have been identified include SNCA (protein alpha-synuclein), UCHL1 (protein ubiquitin carboxy-terminal hydrolase L1), PARK2 (protein parkin), "PARK6" (protein PINK1), PARK7 (protein DJ-1), and PARK7 (protein Dardarin or LRRK2). Indeed, recent linkage studies excluded most of the above gene defects from consideration in the causation of sporadic (i.e. non-familial) Parkinson's disease, which constitutes more than 95% of cases. Most recently, a new gene was identified, ND5, mutation in which is thought to account for a vast majority of sporadic PD cases (see below).

Toxins

One theory holds that the disease may result in many or even most cases from the combination of a genetically determined vulnerability to environmental toxins along with exposure to those toxins. This is argued to be consistent with the fact that Parkinson's disease is not distributed homogenously throughout the population: rather, its incidence varies geographically. The toxins most strongly suspected at present are certain pesticides and industrial metals. MPTP is used as a model for Parkinson's as it can rapidly induce parkinsonian symptoms in human beings and other animals, of any age. Other toxin-based models employ paraquat (a herbicide) in combination with maneb, a fungicide rotenone (an insecticide), and specific organochlorine pesticides including dieldrin and lindane . Studies have found an increase in PD in persons exposed to these agricultural chemicals; the risk apparently rises with exposure.

Read more at Wikipedia.org


[List your site here Free!]


The Parkinson's Disease Treatment Book : Partnering with Your Doctor to Get the Most from Your Medications $17.74 Lucky Man : A Memoir $1.44
HOPE: Four Keys to a Better Quality of Life for Parkinson's People $8.25 Surgery for Parkinson's Disease and Movement Disorders $35.99
Parkinson's Disease & the Art of Moving $12.95 300 Tips for Making Life with Parkinson's Disease Easier $8.19
The Corrections $0.01 100 Questions & Answers About Parkinson Disease (100 Questions and Answers) $4.49
The First Year---Parkinson's Disease: An Essential Guide for the Newly Diagnosed $7.29 Understanding Parkinson's Disease: A Self-Help Guide $0.87

Medication may improve symptoms in Parkinson's disease
Motor fluctuations are a major complication for patients with Parkinson's disease during treatment with levodopa (Larodopa). Adjuvant medications such ...
Parkinson's Disease and the Family
Parkinson's Disease And The Family Nutan Sherma, MD & Elaine Richman Harvard Unviersity Press 79 Garden St., Cambridge, MA 02138 www.hup.harvard.edu ...
Parkinson's disease and nonmotor dysfunction
Parkinson's disease and nonmotor dysfunction. Ed. by Ronald F. Pfeiffer and Ivan Bodis-Wollner. Humana Press Inc. 2005 308 pages $135.00 Hardcover Current clinical neurology RC382
Parkinson's disease
RC382 2004-054497 0-8493-1590-5 Parkinson's disease. Title main entry. Ed. by Manuchair Ebadi and Ronald F. Pfeiffer. CRC Press, [c]2005 1050 p. $199.95 The characteristic shaking a
Benefits and risks of Parkinson's disease drugs
Clinical Question: What are the benefits and risks of monoamine oxidase type B inhibitors in patients with Parkinson's disease? Setting: Outpatient ...
Essential tremor: five million people are afflicted with this inherited disorder, which is often confused with Parkinson's disease
Many an aging person has trembling hands--a sure sign, in their minds, of the onslaught of dreaded Parkinson's disease or embarrassing unsteadiness of old age. Both suspicions may well be unwarra
Riboflavin deficiency as a factor in Parkinson's disease
Of 31 consecutive Brazilian patients (mean age, 67.5 years) with Parkinson's disease, all were found to have evidence of riboflavin deficiency, as assessed ...
The road last traveled: M. Scott Peck's journey with Parkinson's disease - Health Beat
Mention the name M. Scott Peck and back like an echo comes the title The Road Less Traveled. Peck, a quarter-century ago, literally trail-blazed his ...

Home Contact Resources Exchange Links ebay